Increased fibroblast chymase production mediates procollagen autophagic digestion in volume overload
- PMID: 26807691
- PMCID: PMC5198899
- DOI: 10.1016/j.yjmcc.2016.01.019
Increased fibroblast chymase production mediates procollagen autophagic digestion in volume overload
Abstract
Background: Previous work has identified mast cells as the major source of chymase largely associated with a profibrotic phenotype. We recently reported increased fibroblast autophagic procollagen degradation in a rat model of pure volume overload (VO). Here we demonstrate a connection between increased fibroblast chymase production and autophagic digestion of procollagen in the pure VO of aortocaval fistula (ACF) in the rat.
Methods and results: Isolated LV fibroblasts taken from 4 and 12week ACF Sprague-Dawley rats have significant increases in chymase mRNA and chymase activity. Increased intracellular chymase protein is documented by immunocytochemistry in the ACF fibroblasts compared to cells obtained from age-matched sham rats. To implicate VO as a stimulus for chymase production, we show that isolated adult rat LV fibroblasts subjected to 24h of 20% cyclical stretch induces chymase mRNA and protein production. Exogenous chymase treatment of control isolated adult cardiac fibroblasts demonstrates that chymase is internalized through a dynamin-dependent mechanism. Chymase treatment leads to an increased formation of autophagic vacuoles, LC3-II production, autophagic flux, resulting in increased procollagen degradation. Chymase inhibitor treatment reduces cyclical stretch-induced autophagy in isolated cardiac fibroblasts, demonstrating chymase's role in autophagy induction.
Conclusion: In a pure VO model, chymase produced in adult cardiac fibroblasts leads to autophagic degradation of newly synthesized intracellular procollagen I, suggesting a new role of chymase in extracellular matrix degradation.
Keywords: Autophagy; Cardiac fibroblast; Chymase; Intracellular procollagen; Volume overload.
Published by Elsevier Ltd.
Figures







Comment in
-
"Fibroblast" pharmacotherapy - Advancing the next generation of therapeutics for clinical cardiology.J Mol Cell Cardiol. 2016 May;94:176-179. doi: 10.1016/j.yjmcc.2016.03.018. Epub 2016 Apr 6. J Mol Cell Cardiol. 2016. PMID: 27060557 No abstract available.
References
-
- Ryan TD, Rothstein EC, Aban I, Tallaj JA, Husain A, Lucchesi PA, et al. Left ventricular eccentric remodeling and matrix loss are mediated by bradykinin and precede cardiomyocyte elongation in rats with volume overload. J Am Coll Cardiol. 2007;49:811–821. - PubMed
-
- Dell’Italia LJ, Husain A. Dissecting the role of chymase in angiotensin II formation and heart and blood vessel diseases. Curr Opin Cardiol. 2002;17:374–379. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials